Ambegaokar SS et al. Curcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth. Neuroendocrinol Lett 24.6 (2003): 469-73. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med 57.1 (1991): 1-7. Anon. Curcuma longa (turmeric). Altern Med Rev 6 (Suppl) (2001): S62-6.
Anto RJ et al. Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. Mutat Res 370.2 (1996): 127-31.
AntonyS, KuttanR, Kuttan G. Immunomodulatory activity of curcumin. Immunol Invest 28.5-6 (1999): 291303.
Anuchapreeda S et al. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 64.4 (2002): 573-82.
Asai A, Miyazawa T. Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nut. 131.11 (2001): 2932-5.
Azuine MA, Bhide SV. Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr Cancer 17.1 (1992): 77-83.
Babu PS, Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 166.1-2 (1997): 169-75.
Baek O-S et al. Curcumin inhibits protease-activated receptor-2 and -4-mediated mast cell activation. Clin Chim Acta 338.1-2 (2003): 135-41.
Banerjee M et al. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharm Immunotoxicol 25.2 (2003): 213-24.
Bhavani Shankar TN, Shantha NV, Ramesh HP. Toxicity studies on turmeric (Curcuma longa): Acute toxicity studies in rats, guinea pigs and monkeys. Indian J Exp Biol 18.1 (1980): 73-75.
Blumenthal M, Goldberg A, Brinckmann J (eds). Herbal Medicine: Expanded Commission E Monographs. Austin, TX: Integrative Medicine Communications, 2000.
Bosman B. Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol 7.6 (1994): 324-34.
Bush JA, Cheung K-J, Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/ caspase-8 pathway independent of p53. Exp Cell Res 271.2 (2001): 305-14.
Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa) J Altern Complement Med 9.1 (2003): 161-8.
Chang D-M. Curcumin: A heat shock response inducer and potential cytoprotector. Crit Care Med 29.11 (2001): 2231-32.
Cheng AL et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21.4B (2001b): 2895-900.
Chuang SE et al. Curcum in-containing diet inhibits die thylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 21.2 (2000): 331-5.
Chueh S-CJ et al. Curcumin enhances the immunosuppressive activity of cyclosporine in rat cardiac allografts and in mixed lymphocyte reactions. Transplant Proc 35.4 (2003): 1603-5.
Cole GM et al. Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiol Aging Suppl, 2005.
Deodhar SD, Sethi R, Srimal RC. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res 71 (1980): 632-4.
Deshpande URet al. Protective effect of turmeric (Curcuma longa L.) extract on carbon tetrachloride-induced liver damage in rats. Indian J Exp Biol 36.6 (1998): 573-7.
Dorai T et al. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Mol Urol 4.1 (2000): 1-6.
Dorai T et al. Therapeutic potential of curcumin in human prostate cancer III Curcum in inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47.4 (2001): 293-303.
Evans W. Trease and Evans: Pharmacognosy, 15th edn, Edinburgh: WS Saunders, 2002.
Gao X et al. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of Turmeric cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol 68.1 (2004): 51-61.
Garg SK. Effect of Curcuma longa (rhizomes) on fertility in experimental animals. Planta Med 26.3 (1974): 225-7.
Gescher A et al. Suppression of tumour development by substances derived from the diet: mechanisms and clinical implications. Br J Clin Pharmacol 45.1 (1998): 1-12.
Gescher A et al. Cancer chemoprevention by dietary constituents: a tale of failure and promise. Lancet Oncol 2
Gilani AH et al. Pharmacological basis for the use of turmeric in gastrointestinal and respiratory disorders. Life Sei 76.26 (2005): 3089-105.
Gowda NKS et al. Effect of some chemical and herbal compounds on growth of Aspergillus parasiticus and aflatoxin production. Animal Feed Sei Technol 116.3-4 (2004): 281-91.
Gukovsky I et al. Cure um in ameliorates ethanol and nonethanol experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 284.147-1 (2003): G85-95.
Gururaj A et al. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun 297.4 (2002): 934-42.
Hastak K et al. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Lett 116.2 (1997): 265-9.
Hata M et al. Allergic contact dermatitis from curcumin (turmeric). Contact Dermatitis 36.2 (1997): 107-8.
Heng MCY et al. Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol 143.5 (2000): 937-49.
Hergenhahn M et al. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells. Mol Carcinogen 33.3 (2002): 137-45.
Hidaka H et al. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95.6
Hong RL, Spohn WH, Hung MC. Curcumin inhibits tyrosine kinase activity of pl85neu and also depletes pi85neu. Clin Cancer Res 5.7 (1999): 1884-91.
Hour T-C et al. Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAFl/CIPl and C/EBPbeta expressions and suppressing NF-kappaB activation. Prostate 51.3 (2002): 211-18.
Huang M-T et al. Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 13.11 (1992): 2183-6.
Imaida K et al. Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis. Carcinogenesis 22 (2001): 467-72.
Inano H, Onoda M. Radioprotective action of curcumin extracted from Curcuma longa LINN: inhibitory effect on formation of urinary 8-hydroxy-2'-deoxyguanosine, tumorigenesis, but not mortality, induced by gamma-ray irradiation. Int J Radiat Oncol Biol Phys 53 (2002): 735-43.
Iqbal M et al. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol 92.1 (2003): 33-8.
Ireson C et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 61.3 (2001): 1058-64.
Ireson CR et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11.1 (2002): 105-11.
Itthipanichpong C et al. Antispasmodic effects of curcuminoids on isolated guinea-pig ileum and rat uterus. J
Jagetia GC, Rajanikant GK. Role of curcumin, a naturally occurring phenolic compound of turmeric, in Turmeric lit)/
accelerating the repair of excision wound, in mice whole-body exposed to various doses of [gamma] -radiation. J Surg Res 120.1 (2004): 127-38.
Jain SK et al. Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels. Free Radical Biol Med 41.1 (2006): 92-6.
Jayaprakasha GK et al. Chemistry and biological activities of C. longa. Trends Food Sei Technol 16.12 (2005): 533-48.
Jee S-H et al. Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J Invest Dermatol 111.4 (1998): 656-61.
Kang H-C et al. Curcumin inhibits collagen synthesis and hepatic stellate cell activation in-vivo and in-vitro. J Pharm Pharmacol 54.1 (2002): 119-26.
Keshavarz K. The influence of turmeric and curcumin on cholesterol concentration of eggs and tissues. Poultry Sei 55.3 (1976): 1077-83.
Kim MS, Kang HJ, Moon A. Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells. Arch Pharm Res 24.4 (2001): 349-54.
Kositchaiwat C, Kositchaiwat S, Havanondha J. Curcuma longa Linn, in the treatment of gastric ulcer comparison to liquid antacid: a controlled clinical trial. J Med Assoc Thai 76.11 (1993): 601-5.
Kulkarni RR et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 33.1-2 (1991): 91-5.
Kumar GS et al. Free and bound phenolic antioxidants in amla (Emblica officinalis) and turmeric (Curcuma longa). J Food Comp Anal 19.5 (2006): 446-52.
Kuo M-L, Huang T-S, Lin J-K. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochem Biophys Acta Mol Basis Dis 1317.2 (1996): 95-100.
Kuttan Ret al. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29.2 (1985): 197-202.
Kuttan Ret al. Turmeric and curcumin as topical agents in cancer therapy. Tumori 73.1 (1987): 29-31.
Lai B et al. Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res 13.4 (1999): 318-22.
Lai B et al. Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytother Res 14.6 (2000): 443-7.
Lantz RC et al. The effect of turmeric extracts on inflammatory mediator production. Phytomedicine 12.6-7 (2005): 445-52.
Limtrakul P, Anuchapreeda S, Buddhasukh D. Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 4 (2004): 13.
Lukita-Atmadja W et al. Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin. Shock 17.5 (2002): 399-403.
Mani H et al. Curcumin differentially regulates TGF-betal, its receptors and nitric oxide synthase during impaired wound healing. Biofactors 16.1-2 (2002): 29-43.
Meenakshi B, Ashok Antifertility effects of various extracts of Curcuma longa in male albino rats. Indian Drugs 38.2 (2001): 79-81.
Menon LG, Kuttan R, Kuttan, G. Anti-metastatic activity of curcumin and catechin. Cancer Lett 141.1-2 (1999): 159-65.
Mesa MD et al. Oral administration of a turmeric extract inhibits erythrocyte and liver microsome membrane oxidation in rabbits fed with an atherogenic diet. Nutrition 19.9 (2003): 800-4.
Miquel J et al. The curcuma antioxidants: Pharmacological effects and prospects for future clinical use: A review. Arch Gerontol Geriatr 34.1 (2002): 37-46.
Mohan R et al. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B.J Biol Chem 275.14 (2000): 10405-12.
Mohan ty I et al. Protective effects of Curcuma longa on ischemia-re perfusion induced myocardial injuries and their mechanisms. Life Sei 75.14 (2004): 1701-11.
Nabekura T et al. Effects of dietary chemopreventive phytoc hemic als on P-glycoprotein function. Biochem
Biophys Res Commun 327.3 (2005): 866-70. Turmeric 1168
Nagabhushan Mand Bhide SV. Nonmutagenicity of curcumin and its antimutagenic action versus chili and capsaicin. Nutr Cancer 8.3 (1986): 201-10.
Nanji AA et al. Cur cumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappaB-dependent genes. Am J Physiol Gastrointest Liver Physiol 284.2 47-2 (2003): G321-7.
Navis I, Sriganth P, Premalatha B. Dietary cur cum in with cisplatin administration modulates tumour marker indices in experimental fibrosarcoma. Pharmacol Res 39.3 (1999): 175-9.
Niederau C, Gopfert E. [The effect of chelidonium- and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system: Results from a placebo-controlled double-blind study]. Med Klin 94.8 (1999): 425-30.
Perez-Arriaga L et al. Cytotoxic effect of curcumin on Giardia lamblia trophozoites. Acta Tropica 98.2 (2006): 152-61.
Phan T-T et al. Protective effects of curcumin against oxidative damage on skin cells in vitro: Its implication for wound healing. J Trauma-Injury Infect Crit Care 51.5 (2001): 927-31.
Plummer SM et al. Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol Biomarkers Prev 10.12 (2001): 1295-9.
Polasa K et al. Effect of turmeric on urinary mutagens in smokers. Mutagenesis 7.2 (1992): 107-9.
Prucksunand C et al. Phase II clinical trial on effect of the long turmeric (Curcuma longa Linn) on healing of peptic ulcer. Southeast Asian J Trop Med Public Health 32.1 (2001): 208-15.
Quiles JL et al. An ethanolic-aqueous extract of Curcuma longa decreases the susceptibility of liver microsomes and mitochondria to lipid peroxidation in atherosclerotic rabbits. Biofactors 8.1-2 (1998): 51-7.
Quiles JL et al. Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler Thromb Vase Biol 22.7 (2002): 1225-31.
Ram A, Das M, Ghosh B. Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biol Pharm Bull 26.7 (2003): 1021-4.
Ramirez BA et al. Effects of the antioxidant turmeric on lipoprotein peroxides: Implications for the prevention of atherosclerosis. Age 20.3 (1997): 165-8.
Ramirez-Bosca A et al. Antioxidant Curcuma extracts decrease the blood lipid peroxide levels of human subjects. Age 18.4(1995): 167-9.
Ramirez-Tortosa MC et al. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis 147.2 (1999): 3718.
Rao CV et al. Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate. Cancer Res 55.11 (1995a): 2310-15.
Rao CV et al. Chemoprevention of colon cancer by dietary curcumin. Ann NY Acad Sei 768 (1995b): 201-4.
Rao CV et al. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55.2 (1995c): 259-66.
Rao CV et al. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis 20.4 (1999): 641-4.
Rasyid A, Lelo A. The effect of curcumin and placebo on human gall-bladder function: An ultrasound study. Aliment Pharmacol Ther 13.2 (1999): 245-9.
Ray S et al. Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. J Environ Pathol Toxicol Oncol 22.1 (2003): 49-58.
Reddy S, Aggarwal BB. Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett 341.1 (1994): 19-22.
Reddy RC et al. Curcumin for malaria therapy. Biochem Biophys Res Commun 326.2 (2005): 472-4.
Robinson DM. Anaphylaxis to turmeric. J Allergy Clin 111.1 (Suppl 2) (2003): S100.
Ruby AJ et al. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94.1 (1995): 79-83.
Salh B et al. Curcumin attenuates DNB-induced murine colitis. Am J Physiol Gastrointest Liver Physiol 285.1 (2003): G235-43.
Shalini VK, Srinivas L. Lipid peroxide induced DNA damage: protection by turmeric (Curcuma longa). Mol Cell Biochem 77.1 (1987): 3-10.
Sharma RA et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7.7 (2001): 1894-900.
Sidhu GS et al. Enhancement of wound healing by curcumin in animals. Wound Repair Regen 6.2 (1998): 16777.
Sidhu GS et al. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen 7.5 (1999): 362-74.
Song E-K et al. Diarylheptanoids with free radical scavenging and hepatoprotective activity in vitro from Curcuma longa. Planta Med 67.9 (2001): 876-7.
Soni KB, Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 36.4 (1992): 273-5.
Soni KB, Rajan A, Kuttan R. Reversal of aflatoxin induced liver damage by turmeric and curcumin. Cancer Lett 66.2 (1992): 115-21.
Soudamini KK et al. Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin. Indian J Physiol Pharmacol 36.4 (1992): 239-43.
Srinivasan K. Spices as influencers of body metabolism: an overview of three decades of research. Food Res Int 38.1 (2005): 77-86.
Srinivasan K, Sambaiah K. The effect of spices on cholesterol 7 alpha-hydroxylase activity and on serum and hepatic cholesterol levels in the rat. Int J Vitamin Nutr Res 61.4 (1991): 364-9.
Srivastava KC. Extracts from two frequently consumed spices — cumin (Cuminum cyminum) and turmeric (Curcuma longa) — inhibit platelet aggregation and alter eicosanoid biosynthesis in human blood platelets. Prostaglandins Leukot Essent Fatty Acids 37.1 (1989): 57-64.
Srivastava Ret al. Anti-thrombotic effect of curcumin. Thromb Res 40.3 (1985): 413-17.
Srivastava R et al. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis. ArzneimittelForschung 36.4 (1986): 715-17.
Srivastava KC et al. Curcumin, a major component of food spice turmeric (Curcuma longa), inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids 52.4 (1995): 223-27.
Sugiyama T et al. Selective protection of curcumin against carbon tetrachloride-induced inactivation of hepatic cytochrome P450 isozymes in rats. Life Sei 78.19 (2006): 2188-93.
Thaloor D et al. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 9.4 (1998): 305-12.
Thamlikitkul V et al. Randomized double blind study of Curcuma domestica Val for dyspepsia. J Med Assoc Thai 72.11 (1989): 613-20.
Valentine SP et al. Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouse. Life Sei 78.20 (2006): 2391-8.
Verma SP, Salamone E, Goldin B. Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides. Biochem Biophys Res Commun 233.3 (1997): 692-6.
Vijayalaxmi. Genetic effects of turmeric and curcumin in mice and rats. Mutat Res 79.2 (1980): 125-32.
Zahid Ashraf M et al. Antiatherosclerotic effects of dietary supplementations of garlic and turmeric: Restoration of endothelial function in rats. Life Sei 77.8 (2005): 837-57.
Was this article helpful?